{
    "2020-09-28": [
        [
            {
                "time": "2023-11-01",
                "original_text": "Pfizer Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies",
                "features": {
                    "keywords": [
                        "Biotech",
                        "ETFs",
                        "COVID-19",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Sarepta’s First Gene-Therapy Test Patients Look Good, Two Years Out",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "Gene-Therapy",
                        "Patients"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis",
                "features": {
                    "keywords": [
                        "FDA",
                        "Pfizer",
                        "XELJANZ",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Inovio Forced To Delay Planned Testing Of Covid-19 Vaccine; Stock Plummets",
                "features": {
                    "keywords": [
                        "Inovio",
                        "Covid-19",
                        "Vaccine",
                        "Delay",
                        "Stock"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Inovio Stock Tumbles After Covid-19 Vaccine Trial Is Halted",
                "features": {
                    "keywords": [
                        "Inovio",
                        "Stock",
                        "Covid-19",
                        "Vaccine",
                        "Halted"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Official COVID-19 death toll probably underestimates true total - WHO",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "death",
                        "toll",
                        "underestimates",
                        "WHO"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "10 Stocks to Buy as the Health-Care Revolution Races Ahead, According to Experts",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Health-Care",
                        "Revolution",
                        "Experts"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}